Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/27/22 → 04/9/26 |
Funding
- Parexel International LLC: $21,356.30
Ipsen Pharma SAS: A Multicentre, Interventional, Post-marketing, Randomized, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport) in Comparison with OnabotulinumtoxinA (Botox) when Trea
- Schwartz, Guy (PI)
- Muratori, Lisa M (CoPI)
Project: Research